Why the study?
Does oxfenicine improve pacing time to angina and myocardial carbohydrate utilization in patients with obstructive coronary artery disease?
Population
18 patients with obstructive coronary artery disease
Comparison
Oxfenicine (L-hydroxyphenylglycine) 3-12 mg/kg vs Baseline (pre-drug)
Design
Other
Authors
Loading...
May support metabolic modulation in angina; leaves open clinical role pending randomized trials.
Does oxfenicine improve pacing time to angina and myocardial carbohydrate utilization in patients with obstructive coronary artery disease?
Oxfenicine increases myocardial carbohydrate extraction and reduces oxygen consumption, significantly prolonging pacing time to angina in patients with obstructive coronary artery disease.
Bergman et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: